AGL

NEUTRALEarnings

agilon health, inc.

2026-06-18

Price

$113.80

+8.72%

This is the 2026-06-18 snapshot — the signals and analysis for AGL as of this single trading day.

View full AGL research hub →

Score1.5Noise

Signals2/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 9

Volume1.0xvs 20d avg

Analysis

AGL is exhibiting High-Conviction Price Discovery, surging 40.6% over the last month due to a massive Q1 earnings beat, raised full-year guidance, and the recent appointment of new CEO Tim O'Rourke. This fundamental strength is perfectly mirrored by the technicals, where a PERFECT_STACK and GOLDEN_CROSS align with a staggering +39.6% relative strength versus the SPY. Operating within a highly accommodative RISK_ON (GEOPOLITICAL) macro regime, AGL's price action indicates aggressive, structural institutional accumulation rather than speculative noise, warranting a high conviction level.

Fired Signals

GOLDEN CROSSPERFECT STACKEXTENSION

Key Takeaways

Actionable Thesis: Ride the High-Conviction Price Discovery trend fueled by raised fundamental guidance, new executive leadership, and flawless technical alignments.
Key Risk: Extreme annualized volatility of 97.4% leaves the stock vulnerable to sharp, sudden profit-taking pullbacks despite the broader uptrend.
What to Watch: Listen for forward-looking strategic commentary from the new CEO at the upcoming Truist and Citizens healthcare conferences on June 23 and June 25.

← Back to 2026-06-18 View Full AGL History →Yahoo Finance &nearr;